Huihui Zhou, Lin Sang, Yuanyuan Sun, Xue Gong, Jun Zhang, Lina Liu, Junci Wei, Weijie Jiao, Ming Yu
{"title":"Performance of Ultrasonography-Based Fractal Parameters in Distinguishing Hepatocellular Carcinoma From Intrahepatic Cholangiocarcinoma.","authors":"Huihui Zhou, Lin Sang, Yuanyuan Sun, Xue Gong, Jun Zhang, Lina Liu, Junci Wei, Weijie Jiao, Ming Yu","doi":"10.1177/01617346251330257","DOIUrl":null,"url":null,"abstract":"<p><p>To evaluate the ability of fractal parameters based on ultrasonography to distinguish between hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) in patients. This retrospective study was performed to assess the performance of certain ultrasound-based parameters, including fractal dimension (FD), lacunarity (LAC), and FD combined with LAC (FL), in distinguishing HCC from ICC with liver biopsy as the gold standard, information was obtained from 204 eligible patients. Receiver operating characteristic (ROC) curve analysis was conducted, to assess the performance of these parameters in distinguishing between HCC and ICC in patients with or without CLD. The following parameters were significantly different between with and without CLD: the levels of alpha-fetoprotein, abnormal prothrombin, alanine aminotransferase, aspartic acid, total bilirubin and indirect bilirubin (<i>p</i> < .05). The AUC of FL in differentiating HCC from ICC was 0.983 and 0.854 in patients without or with CLD, which were significantly better than that of FD (non-CLD, 0.902 AUC; CLD, 0.647 AUC, <i>p</i> < .05) and LAC (non-CLD, 0.895 AUC; CLD, 0.843 AUC, <i>p</i> < .05). FL can better distinguish between HCC and ICC in patients with or without CLD than FD and LAC. FL may serve as a promising preoperative alternative for distinguishing between the two diseases.Clinical trials:Brief title: Exploration of noninvasive differential diagnosis of benign and malignant liver tumors.URL: https://register.clinicaltrials.govClinicalTrials.gov ID: NCT06524557.</p>","PeriodicalId":49401,"journal":{"name":"Ultrasonic Imaging","volume":" ","pages":"1617346251330257"},"PeriodicalIF":2.5000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ultrasonic Imaging","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/01617346251330257","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ACOUSTICS","Score":null,"Total":0}
引用次数: 0
Abstract
To evaluate the ability of fractal parameters based on ultrasonography to distinguish between hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) in patients. This retrospective study was performed to assess the performance of certain ultrasound-based parameters, including fractal dimension (FD), lacunarity (LAC), and FD combined with LAC (FL), in distinguishing HCC from ICC with liver biopsy as the gold standard, information was obtained from 204 eligible patients. Receiver operating characteristic (ROC) curve analysis was conducted, to assess the performance of these parameters in distinguishing between HCC and ICC in patients with or without CLD. The following parameters were significantly different between with and without CLD: the levels of alpha-fetoprotein, abnormal prothrombin, alanine aminotransferase, aspartic acid, total bilirubin and indirect bilirubin (p < .05). The AUC of FL in differentiating HCC from ICC was 0.983 and 0.854 in patients without or with CLD, which were significantly better than that of FD (non-CLD, 0.902 AUC; CLD, 0.647 AUC, p < .05) and LAC (non-CLD, 0.895 AUC; CLD, 0.843 AUC, p < .05). FL can better distinguish between HCC and ICC in patients with or without CLD than FD and LAC. FL may serve as a promising preoperative alternative for distinguishing between the two diseases.Clinical trials:Brief title: Exploration of noninvasive differential diagnosis of benign and malignant liver tumors.URL: https://register.clinicaltrials.govClinicalTrials.gov ID: NCT06524557.
评价超声分形参数对肝细胞癌(HCC)和肝内胆管癌(ICC)的鉴别能力。本回顾性研究从204例符合条件的患者中获得信息,评估基于超声的某些参数,包括分形维数(FD)、腔间隙(LAC)和FD联合LAC (FL)在区分HCC和以肝活检为金标准的ICC中的表现。进行受试者工作特征(ROC)曲线分析,以评估这些参数在有或没有CLD的患者中区分HCC和ICC的性能。CLD患者与非CLD患者的甲胎蛋白、凝血酶原、丙氨酸转氨酶、天冬氨酸、总胆红素和间接胆红素水平(p p p)均有显著差异
期刊介绍:
Ultrasonic Imaging provides rapid publication for original and exceptional papers concerned with the development and application of ultrasonic-imaging technology. Ultrasonic Imaging publishes articles in the following areas: theoretical and experimental aspects of advanced methods and instrumentation for imaging